Trial Profile

A Randomized, Double-Blind, Bilateral Comparison Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Bilateral Flank Adiposity

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 22 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Polidocanol (Primary)
Indications Obesity
Focus Adverse reactions; First in man; Proof of concept; Therapeutic Use
Sponsors 10xBio

Most Recent Events

18 Mar 2024 Status changed from recruiting to active, no longer recruiting.
06 May 2019 Status changed from planning to recruiting, according to a 10xBio media release.
06 May 2019 Results presented in a 10xBio media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com